Status:

ACTIVE_NOT_RECRUITING

Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer

Lead Sponsor:

Case Comprehensive Cancer Center

Conditions:

Breast Cancer

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to help better understand the uptake and impact of genetic testing for women diagnosed with breast cancer who do not meet National Comprehensive Cancer Network (NCCN) crit...

Detailed Description

This is a randomized trial comparing the effectiveness of pre-test genetic counseling using an artificial intelligence program and traditional in-person genetic counseling in women newly diagnosed wit...

Eligibility Criteria

Inclusion

  • Subjects diagnosed with Stage 0-3 breast cancer.
  • Patients who do not satisfy current NCCN criteria for referral to a genetics counselor and genetics testing.
  • Must have the ability to understand and the willingness to sign a written informed consent document as well as complete the study questionnaires.

Exclusion

  • \- N/A

Key Trial Info

Start Date :

June 29 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2025

Estimated Enrollment :

35 Patients enrolled

Trial Details

Trial ID

NCT04354675

Start Date

June 29 2021

End Date

December 1 2025

Last Update

January 7 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center

Cleveland, Ohio, United States, 44195